Africa News Ledger
SEE OTHER BRANDS

The most trusted news from Africa

Africa News Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.

Press releases published on July 31, 2025

Medicenna Strengthens Intellectual Property Portfolio with Five Patents Granted for its IL-2 and IL-4 Superkines

Medicenna Strengthens Intellectual Property Portfolio with Five Patents Granted for its IL-2 and IL-4 Superkines

TORONTO and HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing novel Superkines for oncology and autoimmune diseases, today …

Oroco Deepens its ESG Commitments to the Santo Tomás Region

Oroco Deepens its ESG Commitments to the Santo Tomás Region

VANCOUVER, Canada, July 31, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTC: ORRCF) (“Oroco” or “the Company”) is pleased to announce it has signed a cooperation agreement with Sembrando Vida (“Sowing Life”), a flagship environmental and …

XORTX Announces USD $114,500 Private Placement

XORTX Announces USD $114,500 Private Placement

CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and …

Voluntary TSX delisting application

Voluntary TSX delisting application

TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) ACN 114 249 026 (Xanadu or the Company) refers to its previous announcement released on 29 July 2025 (Announcement) regarding the Compulsory Acquisition Notice provided by …

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

$12.5 million in second quarter PYRUKYND® (mitapivat) net revenues; ended second quarter with $1.3 billion dollars in cash, cash equivalents and marketable securities PYRUKYND sNDA for thalassemia under active review, with FDA PDUFA goal date of September …

MEXC Launches ETH Launchpad for Ethereum's 10th Anniversary: Users Share 100 ETH at Up to 90% Off

MEXC Launches ETH Launchpad for Ethereum's 10th Anniversary: Users Share 100 ETH at Up to 90% Off

VICTORIA, Seychelles, July 31, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, today announced it has launched its exclusive ETH Launchpad subscription event, offering users the opportunity to share 100 ETH at unprecedented …

MEXC Concludes Golden Era Showdown with 350,000 USDT Gold Bar Awarded in Europe

MEXC Concludes Golden Era Showdown with 350,000 USDT Gold Bar Awarded in Europe

VICTORIA, Seychelles, July 31, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, held an offline awards ceremony in Europe to thank users for their enthusiastic participation in its Golden Era Showdown mid-year trading event. MEXC …

PL BioScience Announces Major Site Expansion

PL BioScience Announces Major Site Expansion

New 1,200 m² facility in Aachen expands headquarters to support company growth and scale Human Platelet Lysate production Site provides the world’s largest HPL output with 20,000L annual capacity and a dual-source GMP strategy for secure, resilient supply …

Pharming Group reports second quarter and first half 2025 financial results and provides business update

Pharming Group reports second quarter and first half 2025 financial results and provides business update

Second quarter 2025 total revenues increased by 26% to US$93.2 million, compared to the second quarter 2024, driven by strong RUCONEST® and Joenja® revenue growth RUCONEST® second quarter revenue increased by 28% to US$80.4 million, compared to the second …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions